Daming Zhou

Employment

Employment history is unavailable.

Education

• University of Oxford

Projects & Funding

Projects & funding information is unavailable.

Publications (49)

• Structural and functional mapping of protective human monoclonal antibodies against enterovirus A71
  Daming Zhou, Abhay Kotecha, James T. Kelly +11 more
  Science Advances 2026 DOI: 10.1126/sciadv.aee8217
  +Save
• A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
  Cell Reports Medicine 2024 DOI: 10.1016/j.xcrm.2024.101553
  +Save
• Amino acid and viral binding by the high-affinity Cationic Amino acid Transporter 1 (CAT1) from Mus musculus
  Research Square 2024 DOI: 10.21203/rs.3.rs-4673967/v1
  +Save
• Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
  Nature Communications 2024 DOI: 10.1038/s41467-024-47393-3
  +Save
• Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
  Proceedings of the National Academy of Sciences of the United States of America 2024 DOI: 10.1073/pnas.2403260121
  +Save
• The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
  Nature Communications 2024 DOI: 10.1038/s41467-024-46982-6
  +Save
• A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
  Cell Reports 2023 DOI: 10.1016/j.celrep.2022.111903
  +Save
• Broadly neutralizing antibodies against COVID-19
  Current Opinion in Virology 2023 DOI: 10.1016/j.coviro.2023.101332
  +Save
• Cooperativity and induced oligomerisation control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies
  Biorxiv 2023 DOI: 10.1101/2023.09.14.557399
  +Save
• Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
  Research Square 2023 DOI: 10.21203/rs.3.rs-3689322/v1
  +Save
• Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
  Nature Communications 2023 DOI: 10.1038/s41467-023-37826-w
  +Save
• Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2
  Research Square 2023 DOI: 10.21203/rs.3.rs-2684849/v1
  +Save
• Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
  Cell Reports 2023 DOI: 10.1016/j.celrep.2023.112271
  +Save
• Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
  Cell 2022 DOI: 10.1016/j.cell.2022.06.005
  +Save
• Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
  Cell Discovery 2022 DOI: 10.1038/s41421-022-00493-0
  +Save
• Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
  Biorxiv 2022 DOI: 10.1101/2022.05.21.492554
  +Save
• Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
  Biorxiv 2022 DOI: 10.1101/2022.07.14.500063
  +Save
• Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum
  Cell Discovery 2022 DOI: 10.1038/s41421-022-00482-3
  +Save
• Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
  Cell 2022 DOI: 10.1016/j.cell.2022.05.014
  +Save
• SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
  Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou +97 more
  Cell 2022 DOI: 10.1016/j.cell.2021.12.046
  +Save